scholarly journals Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma (MM) in HIV Positive Patients (PTS) in the Highly Active Antiretroviral Therapy (HAART) Era

2011 ◽  
Vol 17 (2) ◽  
pp. S253-S254
Author(s):  
A. Restrepo ◽  
M. Cottler-Fox ◽  
M. Grazziutti ◽  
N. Sanath Kumar ◽  
E.J. Anaissie
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Antiretroviral Therapy ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Autologous Stem Cell Transplantation ◽  
Highly Active Antiretroviral Therapy ◽  
Hiv Positive ◽  
Highly Active

Comparable survival between HIV+ and HIV− non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation

Blood ◽  
2009 ◽  
Vol 113 (23) ◽  
pp. 6011-6014 ◽  
Author(s):  
José L. Díez-Martín ◽  
Pascual Balsalobre ◽  
Alessandro Re ◽  
Mariagrazia Michieli ◽  
José M. Ribera ◽  
...  
Keyword(s):  
Stem Cell ◽  
Antiretroviral Therapy ◽  
Stem Cell Transplantation ◽  
Hodgkin Lymphoma ◽  
Cell Transplantation ◽  
Highly Active Antiretroviral Therapy ◽  
Bacterial Infections ◽  
Progression Free Survival ◽  
Highly Active ◽  
Total Body

AbstractAutologous stem cell transplantation (ASCT) has been successfully used in HIV-related lymphoma (HIV-Ly) patients on highly active antiretroviral therapy. We report the first comparative analysis between HIV-Ly and a matched cohort of HIV− lymphoma patients. This retrospective European Group for Blood and Marrow Transplantation study included 53 patients (66% non-Hodgkin and 34% Hodgkin lymphoma) within each cohort. Both groups were comparable except for the higher proportion of males, mixed-cellularity Hodgkin lymphoma and patients receiving granulocyte colony-stimulating factor before engraftment and a smaller proportion receiving total body irradiation-based conditioning within the HIV-Ly cohort. Incidence of relapse, overall survival, and progression-free survival were similar in both cohorts. A higher nonrelapse mortality within the first year after ASCT was observed in the HIV-Ly group (8% vs 2%), predominantly because of early bacterial infections, although this was not statistically significant and did not influence survival. Thus, within the highly active antiretroviral therapy era, HIV patients should be considered for ASCT according to the same criteria adopted for HIV− lymphoma patients.

scholarly journals Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma

2021 ◽  
Vol 11 (3) ◽  
Author(s):  
Kalyan Nadiminti ◽  
M. Hasib Sidiqi ◽  
Kapil Meleveedu ◽  
Hassan B. Alkhateeb ◽  
William J. Hogan ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Autologous Stem Cell Transplantation ◽  
Myeloid Neoplasms
Sign in / Sign up

Export Citation Format

Share Document